CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Whanin Pharm Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Whanin Pharm Co Ltd
117, Saemal-Ro, Songpa-Gu
Phone: +82 24053000p:+82 24053000 SEOUL, 05809  South Korea Ticker: 016580016580
Business Summary
Whanin Pharm Co Ltd is a Korea-based company engaged in the manufacturing of pharmaceutical products. The Company's products mainly include mental illness treatments, antidepressants, anti-schizophrenia drugs, cognitive improvement drugs, dementia treatments, anticonvulsants, digestive system drugs, antibiotics, antipyretics and analgesics, anti-inflammatory drugs, endocrine system drugs, respiratory system drugs and circulatory disorder drugs, ulcer treatment, liver protection and osteoporosis prevention treatment. The Company is also engaged in the real estate leasing business.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
6512 Operators of nonresidential buildings

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Co-Chief Executive Officer, Director Won BeomLee 38 12/31/2012 3/12/2010
Vice Chairman Gye GwanLee 67 1/1/2012 1/1/2012
Vice President, Director Byeong YeonYoo 61 3/12/2010 12/31/2006
11 additional Officers and Directors records available in full report.

Business Names
Business Name
016580
WHANIN PHARM CO.,LTD
Whanin Pharmaceutical Co., Ltd.

General Information
Number of Employees: 663 (As of 9/30/2023)
Outstanding Shares: 15,267,070 (As of 9/30/2024)
Shareholders: 15,244
Stock Exchange: KRX
Fax Number: +82 24042518


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, November 21, 2024